Skip to Content


Active substance(s): REPAGLINIDE

View full screen / Print PDF » Download PDF ⇩
Marketing Authorisation Holder - Rivopharm UK Ltd., 30th Floor,
40 Bank Street, Canary Wharf, London E14 5NR

This leaflet was last approved in: 01/2016

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.